The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients

BACKGROUND: BRAF and KRAS mutations are well-established biomarkers in anti-EGFR therapy. However, the prognostic significance of these mutations is still being examined. We determined the prognostic value of BRAF and KRAS mutations in Korean colorectal cancer (CRC) patients. METHODS: From July 2010...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Daeyoun David, Lee, Jae Im, Lee, In Kyu, Oh, Seong-Taek, Jung, Eun Sun, Lee, Sung Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460473/
https://www.ncbi.nlm.nih.gov/pubmed/28583095
http://dx.doi.org/10.1186/s12885-017-3381-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460473/
https://www.ncbi.nlm.nih.gov/pubmed/28583095
http://dx.doi.org/10.1186/s12885-017-3381-7

Ejemplares similares